Literature DB >> 9288680

Stimulation of alpha 1-adrenoceptors and protein kinase C-mediated activation of ecto-5'-nucleotidase in rat hearts in vivo.

T Sato1, T Obata, Y Yamanaka, M Arita.   

Abstract

1. To determine whether protein kinase C (PKC)-mediated activation of ecto-5'-nucleotidase would increase interstitial adenosine concentrations in the rat heart in vivo, we made use of the microdialysis technique and a flexibly mounted probe, which was implanted in the left ventricular myocardium and perfused with Tyrode solution. 2. The baseline level of dialysate adenosine was 0.51 +/- 0.09 microM (n = 16). Perfusion of adenosine 5'-monophosphate (AMP, 100 microM) through the probe increased the dialysate adenosine concentration markedly to 9.25 +/- 0.46 microM (n = 15). alpha, beta-Methyleneadenosine 5'-diphosphate (AOPCP, 100 microM), an inhibitor of ecto-5'-nucleotidase, abolished the AMP-induced increase in dialysate adenosine, but did not affect the baseline level of adenosine. These observations suggest that the dialysate adenosine obtained during the perfusion with AMP, but not the baseline levels of adenosine, originated from the dephosphorylation of AMP by ecto-5'-nucleotidase. Thus, the level of adenosine measured during AMP perfusion gives an index of the activity of ecto-5'-nucleotidase in the tissue. 3. Noradrenaline (10 microM) increased the adenosine concentration measured in the presence of 100 microM AMP (i.e. the activity of ecto-5'-nucleotidase) by 38.7 +/- 9.6% (n = 5, P < 0.05), an increase which was inhibited by an antagonist of the alpha 1-adrenoceptor (prazosin, 50 microM) or of PKC (chelerythrine, 10 microM). Further application of either the alpha 1-adrenoceptor agonist methoxamine (100 microM) or the diacylglycerol analogue 1,2-dioctanoyl-sn-glycerol (DOG, 100 microM) also increased the adenosine concentration by 35.1 +/- 10.0% (n = 6, P < 0.05) or 40.6 +/- 8.3% (n = 5, P < 0.05), respectively. 4. The presence of okadaic acid (50 microM), an inhibitor of protein phosphatase, enhanced the noradrenaline-induced increase in adenosine concentration by 112.4 +/- 35.9% (n = 4, P < 0.05), to a level significantly (P < 0.05) greater than the increase caused by noradrenaline alone (38.7 +/- 9.6%). 5. These data provide the first evidence that alpha 1-adrenoceptor stimulation and the subsequent activation of PKC can increase adenosine concentrations in interstitial spaces of ventricular muscle in vivo, through activation of endogenous ecto-5'-nucleotidase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9288680      PMCID: PMC1159892          DOI: 10.1111/j.1469-7793.1997.119bi.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  27 in total

1.  Transmural distribution of extracellular purines in isolated guinea pig heart.

Authors:  Q Y Zhu; J P Headrick; R M Berne
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

2.  In vitro regulation of rat heart 5'-nucleotidase by adenine nucleotides and magnesium.

Authors:  J M Sullivan; J B Alpers
Journal:  J Biol Chem       Date:  1971-05-10       Impact factor: 5.157

3.  Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics.

Authors:  C Bialojan; A Takai
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

4.  Chelerythrine is a potent and specific inhibitor of protein kinase C.

Authors:  J M Herbert; J M Augereau; J Gleye; J P Maffrand
Journal:  Biochem Biophys Res Commun       Date:  1990-11-15       Impact factor: 3.575

5.  Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart.

Authors:  G S Liu; J Thornton; D M Van Winkle; A W Stanley; R A Olsson; J M Downey
Journal:  Circulation       Date:  1991-07       Impact factor: 29.690

Review 6.  Regulation of adenosine formation by the heart.

Authors:  H V Sparks; H Bardenheuer
Journal:  Circ Res       Date:  1986-02       Impact factor: 17.367

7.  Cardiac microdialysis to estimate interstitial adenosine and coronary blood flow.

Authors:  D G Van Wylen; J Willis; J Sodhi; R J Weiss; R D Lasley; R M Mentzer
Journal:  Am J Physiol       Date:  1990-06

Review 8.  Adenosine, the heart, and coronary circulation.

Authors:  M Hori; M Kitakaze
Journal:  Hypertension       Date:  1991-11       Impact factor: 10.190

9.  Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction.

Authors:  J D Thornton; G S Liu; R A Olsson; J M Downey
Journal:  Circulation       Date:  1992-02       Impact factor: 29.690

10.  Adenosine A1 receptor mediated protection of the globally ischemic isolated rat heart.

Authors:  R D Lasley; J W Rhee; D G Van Wylen; R M Mentzer
Journal:  J Mol Cell Cardiol       Date:  1990-01       Impact factor: 5.000

View more
  2 in total

1.  Stimulation of an alpha1-adrenergic receptor downregulates ecto-5' nucleotidase activity on the apical membrane of RPE cells.

Authors:  David Reigada; Xiulan Zhang; Ana Crespo; Johnathan Nguyen; Ji Liu; Klara Pendrak; Richard A Stone; Alan M Laties; Claire Mitchell
Journal:  Purinergic Signal       Date:  2006-08-11       Impact factor: 3.765

Review 2.  Adenosine A₂a receptors and O₂ sensing in development.

Authors:  Brian J Koos
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.